NASDAQ:QNCX

Quince Therapeutics Stock Pauses After Volatile Biotech Moves

Quince Therapeutics Stock Pauses After Volatile Biotech Moves

Quince Therapeutics shares closed Friday at $1.10, up 2.8% for the day but down 4.3% for the week. Nasdaq confirmed Quince regained listing compliance after reporting $15.7 million in stockholders’ equity. The company announced the acquisition of Orphai and a planned $187 million private financing. Markets were closed Monday for Memorial Day; trading resumes Tuesday.
May 25, 2026

Stock Market Today

  • Victorian government to tighten IVF clinic regulation after Monash IVF errors
    June 1, 2026, 8:32 PM EDT. The Victorian government plans stricter regulations for IVF clinics following high-profile embryo mix-ups involving Monash IVF. Health Minister Harriet Shing will gain authority to cancel clinic registrations and enforce rigorous accreditation standards under a national framework led by the Australian Commission on Safety and Quality in Health Care. The moves aim to address inconsistencies in state regulations and improve patient safety with measures like performance metrics, workforce guidelines, and safety rules for new technologies. Clinics will face a standard three-year registration, subject to review or shortening if risks are identified. Additional powers include health department inspections and equipment seizures. The changes follow a government-initiated review revealing significant shortcomings in the IVF sector.